Structural differences between A7beta;(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange

Biophysical Journal

Volumn 96, Issue 3, 2009, Pages 1091-1104

  Zhang, Aming ^a   Qi, Wei ^a   Good, Theresa A ^b   Fernandez, Erik J ^a  

^a University of Virginia   (United States)

^b University of Marylandw Baltimore County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; OLIGOMER; SOLVENT; AMYLOID; AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DEUTERIUM HYDROGEN EXCHANGE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NEUROTOXICITY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; ARTIFACT; CHEMISTRY; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; AMYLOID; AMYLOID BETA-PROTEIN; ARTIFACTS; DEUTERIUM EXCHANGE MEASUREMENT; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; SOLVENTS;

EID: 61549108314     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2008.10.022     Document Type: Article

References (56)

1. Hardy, J. A., and G. A. Higgins. 1992. Alzheimer's disease-the amyloid cascade hypothesis. Science. 256:184-185.
2. Hardy, J., and D. J. Selkoe. 2002. Medicine-the amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:353-356.
3. Ban, T., and Y. Goto. 2006. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy. Methods Enzymol. 413:91-102.
4. Blackley, H. K. L., G. H. W. Sanders, M. C. Davies, C. J. Roberts, S. J. B. Tendler, et al. 2000. In-situ atomic force microscopy study of beta-amyloid fibrillization. J. Mol. Biol. 298:833-840.
5. Chen, X. G., S. K. Brining, V. Q. Nguyen, and A. L. Yergey. 1997. Simultaneous assessment of conformation and aggregation of beta- amyloid peptide using electrospray ionization mass spectrometry. FASEBJ. 11:817-823.
6. Goldsbury, C., P. Frey, V. Olivieri, U. Aebi, and S. A. Muller. 2005. Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J. Mol. Biol. 352:282-298.
7. Harper, J. D., S. S. Wong, C. M. Lieber, and P. T. Lansbury. 1999. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry. 38:8972-8980.
8. Pallitto, M. M., and R. M. Murphy. 2001. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys. J. 81:1805-1822.
9. Lomakin, A., D. B. Teplow, D. A. Kirschner, and G. B. Benedek. 1997. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc. Natl. Acad. Sci. USA. 94:7942-7947.
10. Kayed, R., E. Head, J. L. Thompson, T. M. Mclntire, S. C. Milton, et al. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:486-489.
11. Bucciantini, M., E. Giannoni, F. Chiti, F. Baroni, L. Formigli, et al. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
12. Lambert, M. P., A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, et al. 1998. Diffusible, nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:6448-6453.
13. Lee, S., E. J. Fernandez, and T. A. Good. 2007. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the A beta fibril formation pathway. Protein Sci. 16:723-732.
14. Kirkitadze, M. D., M. M. Condron, and D. B. Teplow. 2001. Identification and characterization of key kinetic intermediates in amyloid beta- protein fibrillogenesis. J. Mol. Biol. 312:1103-1119.
15. Antzutkin, O. N., R. D. Leapman, J. J. Balbach, and R. Tycko. 2002. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry. 41:15436-15450.
16. Luhrs, T., C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, et al. 2005. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 102:17342-17347.
17. Petkova, A. T., W. M. Yau, and R. Tycko. 2006. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry. 45:498-512.
18. Mastrangelo, I. A., M. Ahmed, T. Sato, W. Liu, C. Wang, et al. 2006. High-resolution atomic force microscopy of soluble Abeta42 oligomers. J. Mol. Biol. 358:106-119.
19. Bitan, G., M. D. Kirkitadze, A. Lomakin, S. S. Vollers, G. B. Benedek, et al. 2003. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA. 100:330-335.
20. Goldsbury, C. S., S. Wirtz, S. A. Muller, S. Sunderji, P. Wicki, et al. 2000. Studies on the in vitro assembly of A beta 1-40: implications for the search for A beta fibril formation inhibitors. J. Struct. Biol. 130:217-231.
21. Harper, J. D., S. S. Wong, C. M. Lieber, and P. T. Lansbury. 1997. Observation of metastable A beta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:119-125.
22. Harper, J. D., C. M. Lieber, and P. T. Lansbury, Jr. 1997. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 4:951-959.
23. Walsh, D. M., A. Lomakin, G. B. Benedek, M. M. Condron, and D. B. Teplow. 1997. Amyloid beta-protein fibrillogenesis-detection of a protofibrillar intermediate. J. Biol. Chem. 272:22364-22372.
24. Kayed, R., Y. Sokolov, B. Edmonds, T. M. Mclntire, S. C. Milton, et al. 2004. Permeabilization of lipid bilayers is a common conformation- dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279:46363-46366.
25. Qi, W. Z. A., D. Patel, S. Lee, J. L. Harrington, L. M. Zhao, et al. 2008. Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: application to Abeta (1-40) fibrillogenesis. Biotechnol. Bioeng. 100:1214-1227.
26. Kheterpal, I., M. Chen, K. D. Cook, and R. Wetzel. 2006. Structural differences in A beta amyloid protofibrils and fibrils mapped by hydrogen exchange-mass spectrometry with on-line proteolytic fragmentation. J. Mol. Biol. 361:785-795.
27. Kheterpal, I., R. Wetzel, and K. D. Cook. 2003. Enhanced correction methods for hydrogen exchange-mass spectrometric studies of amyloid fibrils. Protein Sci. 12:635-643.
28. Klunk, W. E., R. F. Jacob, and R. P. Mason. 1999. Quantifying amyloid beta-peptide (A beta) aggregation using the Congo red A beta (CR-A beta) spectrophotometric assay. Anal. Biochem. 266:66-76.
29. Wang, S. S. -S., S. A. Tobler, T. A. Good, and E. J. Fernandez. 2003. Hydrogen exchange-mass spectrometry analysis of beta-amyloid peptide structure. Biochemistry. 42:9507-9514.
30. Olofsson, A., M. Lindhagen-Persson, A. E. Sauer-Eriksson, and A. Ohman. 2007. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions. Biochem. J. 404:63-70.
31. Petkova, A. T., Y. Ishii, J. J. Balbach, O. N. Antzutkin, R. D. Leapman, et al. 2002. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 99:16742-16747.
32. Williams, A. D., E. Portelius, I. Kheterpal, J. -t. Guo, K. D. Cook, et al. 2004. Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335:833-842.
33. Reference deleted in proof.
34. Walsh, D. M., D. M. Hartley, Y. Kusumoto, Y. Fezoui, M. M. Condron, et al. 1999. Amyloid beta-protein fibrillogenesis-structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:25945-25952.
35. Kheterpal, I., S. Zhou, K. D. Cook, and R. Wetzel. 2000. Aβ amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc. Natl. Acad. Sci. USA. 97:13597-13601.
36. Williams, A. D., M. Sega, M. Chen, I. Kheterpal, M. Geva, et al. 2005. Structural properties of Aβ protofibrils stabilized by a small molecule. Proc. Natl. Acad. Sci. USA. 102:7115-7120.
37. Rochet, J. C., and P. T. Lansbury. 2000. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10:60-68.
38. Murphy, R. M. 2007. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim. Biophys. Acta. 1768:1923-1934.
39. Kim, J. R., andR. M. Murphy. 2004. Mechanismofacceleratedassembly of beta-amyloid filaments into fibrils by KLVFFK6. Biophys. J. 86: 3194-3203.
40. Wood, S. J., R. Wetzel, J. D. Martin, and M. R. Hurle. 1995. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/a4. Biochemistry. 34:724-730.
41. Maji, S. K., J. J. Amsden, K. J. Rothschild, M. M. Condron, and D. B. Teplow. 2005. Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence. Biochemistry. 44:13365-13376.
42. Lazo, N. D., M. A. Grant, M. C. Condron, A. C. Rigby, and D. B. Teplow. 2005. On the nucleation of amyloid beta-protein monomer folding. Protein Sci. 14:1581-1596.
43. Borreguero, J. M., B. Urbanc,N. D. Lazo, S. V. Buldyrev, D. B. Teplow, et al. 2005. Folding events in the 21-30 region of amyloid-beta-protein (A beta) studied in silico. Proc. Natl. Acad. Sci. USA. 102:6015-6020.
44. Cruz, L., B. Urbanc, J. M. Borreguero, N. D. Lazo, D. B. Teplow, et al. 2005. Solvent and mutation effects on the nucleation of amyloid beta- protein folding. Proc. Natl. Acad. Sci. USA. 102:18258-18263.
45. Chimon, S., and Y. Ishii. 2005. Capturing intermediate structures of Alzheimer's β-amyloid, Ab(1-40), by solid-state NMR spectroscopy. J. Am. Chem. Soc. 127:13472-13473.
46. Jang, S., and S. Shin. 2008. Computational study on the structural diversity of amyloid Beta Peptide (abeta(10-35)) oligomers. J. Phys. Chem. B. 112:3479-3484.
47. Nguyen, P. H., M. S. Li, G. Stock, J. E. Straub, and D. Thirumalai. 2007. Monomer adds to preformed structured oligomers of Abeta- peptides by a two-stage dock-lock mechanism. Proc. Natl. Acad. Sci. USA. 104:111-116.
48. Cheon, M., I. Chang, S. Mohanty, L. M. Luheshi, C. M. Dobson, et al. 2007. Structural reorganization and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput. Biol. 3:1727-1738.
49. Kheterpal, I., A. Williams, C. Murphy, B. Bledsoe, and R. Wetzel. 2001. Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry. 40:11757-11767.
50. Shivaprasad, S., and R. Wetzel. 2006. Scanning cysteine mutagenesis analysis of A beta-(1-40) amyloid fibrils. J. Biol. Chem. 281:993-1000.
51. Reference deleted in proof.
52. Zheng, J., H. Jang, B. Ma, and R. Nussinov. 2008. Annular structures as intermediates in fibril formation of Alzheimer A beta(17-42). J. Phys. Chem. B. 112:6856-6865.
53. Garzon-Rodriguez, W., A. Vega, M. Sepulveda-Becerra, S. Milton, D. A. Johnson, et al. 2000. A conformation change in the carboxyl terminus of Alzheimer's A beta(1-40) accompanies the transition from dimer to fibril as revealed by fluorescence quenching analysis. J. Biol. Chem. 275:22645-22649.
54. Simmons, L. K., P. C. May, K. J. Tomaselli, R. E. Rydel, K. S. Fuson, et al. 1994. Secondary structure of amyloid beta-peptide correlates with neurotoxic activity in-vitro. Mol. Pharmacol. 45:373-379.
55. Hertel, C., E. Terzi, N. Hauser, R. Jakob-Rotne, J. Seelig, et al. 1997. Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc. Natl. Acad. Sci. USA. 94:9412-9416.
56. Curtain, C. C., F. Ali, I. Volitakis, R. A. Cherny, R. S. Norton, et al. 2001. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing super- oxide dismutase-like subunits. J. Biol. Chem. 276:20466-20473.